Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 55 results for "Chronic Myeloid Leukemia (CML)".

Thumbnail for Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

CML - 115

Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

CML - 1166

Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

Previous 1 2 3 4 5...7 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

CML - 1215

A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

Rahul Kumar Thakur

Poster Presenter: Rahul Kumar Thakur

Thumbnail for Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy

CML - 1221

Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy

Rudra Narayan Swain

Poster Presenter: Rudra Narayan Swain

Thumbnail for Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

CML - 124

Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

CML - 1247

Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Nadezhda Shnalieva

Poster Presenter: Nadezhda Shnalieva

Thumbnail for Rising Cardiovascular Comortality Among Decedents With Chronic Myeloid Leukemia in the United States, 2003-2024

CML - 1249

Rising Cardiovascular Comortality Among Decedents With Chronic Myeloid Leukemia in the United States, 2003-2024

Kristina Agustino

Poster Presenter: Kristina Agustino

Thumbnail for Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

CML - 1331

Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

Adeel Khan

Poster Presenter: Adeel Khan

Thumbnail for Cumulative Imatinib Exposure Is Associated With Renal but Not Skeletal Dysfunction in Chronic Phase CML

CML - 1344

Cumulative Imatinib Exposure Is Associated With Renal but Not Skeletal Dysfunction in Chronic Phase CML

AKSHAY MIDDINTI

Poster Presenter: AKSHAY MIDDINTI

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors